acpalmer.bsky.social
@acpalmer.bsky.social
New paper, with Amy Pomeroy!
A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma
now out in Blood Cancer Discovery:
doi.org/10.1158/2643...
#mathonc #lymsm #BloodCancer
1/n
A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma
now out in Blood Cancer Discovery:
doi.org/10.1158/2643...
#mathonc #lymsm #BloodCancer
1/n
A model of intra-tumor and inter-patient heterogeneity explains clinical trials of curative combination therapy for lymphoma
Abstract. Models of tumor drug response have illuminated important concepts in oncology, but there remains a need for theory that combines intra-tumor and inter-patient heterogeneity to explain patien...
doi.org
April 10, 2025 at 2:57 AM
New paper, with Amy Pomeroy!
A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma
now out in Blood Cancer Discovery:
doi.org/10.1158/2643...
#mathonc #lymsm #BloodCancer
1/n
A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma
now out in Blood Cancer Discovery:
doi.org/10.1158/2643...
#mathonc #lymsm #BloodCancer
1/n